Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-III Rectal Cancer

NCT07394192 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer
Radiotherapy
PD-1 Inhibitor

Interventions

RADIATION: short-course radiotherapy that preserves tumor-draining lymph nodes

Sponsor

Peking University Cancer Hospital & Institute